🌎 Ferrari Downgraded, Trex Downgraded, Microsoft Initiated and more...
Ratings changes for Microsoft, C4 Therapeutics, T-Mobile US, ACADIA Pharmaceuticals, Richardson Electronics, Exact Sciences, The Liberty SiriusXM Group and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.
VIEW MY PORTFOLIO
December 13th, 2023
Americans Now Favor Gold Over Stocks as an Investment Vehicle (ad)
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Unlock the Power of Tomorrow with the #1 Alternative Energy Stock! (ad)
Are you ready to invest in a brighter, greener future? Look no further – the #1 Alternative Energy Stock is here, leading the charge towards sustainable and profitable solutions! By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
Microsoft Co. (NASDAQ:MSFT) announced a quarterly dividend on Monday, September 18th. Shareholders of record on Thursday, November 16th will be paid a dividend of 0.75 per share by the software giant on Thursday, December 14th. This represents a $3.00 annualized dividend and a yield of 0.80%. The ex-dividend date of this dividend is Wednesday, November 15th. This is an increase from Microsoft's previous quarterly dividend of $0.68.
Microsoft (NASDAQ:MSFT) is now covered by analysts at Truist Financial Co. (). They set a "buy" rating on the stock.The current price is $374.31.
Ally Financial (NYSE:ALLY) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $31.00 price target on the stock, up previously from $23.00. This represents a 2.4% upside from the current price of $30.28.
Basf (OTCMKTS:BASFY) was upgraded by analysts at UBS Group AG from a "sell" rating to a "buy" rating.The current price is $12.26.
C4 Therapeutics (NASDAQ:CCCC) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock, up previously from $2.00. This represents a 177.8% upside from the current price of $4.32.
Capital One Financial (NYSE:COF) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $120.00 price target on the stock, up previously from $87.00. This represents a 0.5% downside from the current price of $120.56.
D.R. Horton (NYSE:DHI) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $164.00 price target on the stock, up previously from $148.00. This represents a 17.3% upside from the current price of $139.85.
Gogoro (NASDAQ:GGR) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $2.20 price target on the stock. This represents a 9.1% downside from the current price of $2.42.
Health Catalyst (NASDAQ:HCAT) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $11.00 price target on the stock, down previously from $14.00. This represents a 45.3% upside from the current price of $7.57.
Incyte (NASDAQ:INCY) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $78.00 price target on the stock. This represents a 22.4% upside from the current price of $63.71.
MFA Financial (NYSE:MFA) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $12.00 price target on the stock, up previously from $11.25. This represents a 7.0% upside from the current price of $11.22.
Mohawk Industries (NYSE:MHK) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $100.00 price target on the stock, up previously from $80.00. This represents a 7.7% upside from the current price of $92.85.
MSCI (NYSE:MSCI) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $600.00 price target on the stock, up previously from $526.00. This represents a 13.1% upside from the current price of $530.70.
Realty Income (NYSE:O) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating. They now have a $63.00 price target on the stock. This represents a 14.6% upside from the current price of $54.98.
Opendoor Technologies (NASDAQ:OPEN) was upgraded by analysts at Keefe, Bruyette & Woods from an "underperform" rating to a "market perform" rating. They now have a $3.50 price target on the stock, up previously from $1.65. This represents a 2.2% downside from the current price of $3.58.
Pentair (NYSE:PNR) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $82.00 price target on the stock. This represents a 22.8% upside from the current price of $66.80.
Q2 (NYSE:QTWO) was upgraded by analysts at Piper Sandler from an "underweight" rating to a "neutral" rating. They now have a $41.00 price target on the stock, up previously from $30.00. This represents a 6.4% upside from the current price of $38.52.
Radian Group (NYSE:RDN) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $29.00 price target on the stock. This represents a 8.2% upside from the current price of $26.79.
RxSight (NASDAQ:RXST) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $42.00 price target on the stock, up previously from $31.00. This represents a 9.5% upside from the current price of $38.37.
Volkswagen (OTCMKTS:VWAGY) was upgraded by analysts at BNP Paribas from an "underperform" rating to a "neutral" rating.The current price is $13.40.
Xponential Fitness (NYSE:XPOF) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. This represents a 82.2% upside from the current price of $9.88.
A multimillionaire stock trader's research explains how focusing on just one ticker every week has generated payouts up to a rare 2,614% in under 11 days...AND he's brought proof to show the world!
Agree Realty (NYSE:ADC) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $64.00 price target on the stock. This represents a 7.1% upside from the current price of $59.78.
Aveanna Healthcare (NASDAQ:AVAH) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.The current price is $2.18.
Bread Financial (NYSE:BFH) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $25.00 price target on the stock, down previously from $31.00. This represents a 17.9% downside from the current price of $30.46.
Church & Dwight (NYSE:CHD) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $90.00 price target on the stock. This represents a 4.6% downside from the current price of $94.36.
Coherent (NYSE:COHR) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $45.00 price target on the stock, up previously from $39.00. This represents a 10.9% upside from the current price of $40.58.
Ford Motor (NYSE:F) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $12.00 price target on the stock. This represents a 10.2% upside from the current price of $10.89.
Hillman Solutions (NASDAQ:HLMN) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $9.00 price target on the stock. This represents a 16.0% upside from the current price of $7.76.
Hertz Global (NASDAQ:HTZ) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $8.65.
Inspire Medical Systems (NYSE:INSP) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $187.00 price target on the stock, down previously from $245.00. This represents a 4.8% upside from the current price of $178.50.
Johnson Controls International (NYSE:JCI) was downgraded by analysts at Vertical Research from a "buy" rating to a "hold" rating. They now have a $55.00 price target on the stock. This represents a 5.8% upside from the current price of $52.00.
Johnson & Johnson (NYSE:JNJ) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $163.00 price target on the stock, down previously from $170.00. This represents a 5.7% upside from the current price of $154.22.
LyondellBasell Industries (NYSE:LYB) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $98.00 price target on the stock, down previously from $105.00. This represents a 7.8% upside from the current price of $90.88.
Model N (NYSE:MODN) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $30.00. This represents a 11.4% upside from the current price of $22.45.
NexPoint Real Estate Finance (NYSE:NREF) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating.The current price is $15.72.
NETSTREIT (NYSE:NTST) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $17.00 price target on the stock. This represents a 3.3% upside from the current price of $16.45.
Ferrari (NYSE:RACE) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating.The current price is $365.20.
Ferrari (NYSE:RACE) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating.The current price is $365.20.
R1 RCM (NASDAQ:RCM) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $11.00 price target on the stock, down previously from $20.00. This represents a 11.0% upside from the current price of $9.91.
Shell (NYSE:SHEL) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating.The current price is $63.33.
Trex (NYSE:TREX) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $74.00 price target on the stock, up previously from $66.00. This represents a 2.5% upside from the current price of $72.19.
Visteon (NASDAQ:VC) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $130.00 price target on the stock. This represents a 9.5% upside from the current price of $118.67.
Walker & Dunlop (NYSE:WD) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $105.00 price target on the stock, up previously from $85.00. This represents a 9.9% upside from the current price of $95.50.
Western Midstream Partners (NYSE:WES) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $27.00 price target on the stock, down previously from $30.00. This represents a 0.1% upside from the current price of $26.98.
WPP (NYSE:WPP) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.The current price is $45.19.
Zurn Elkay Water Solutions (NYSE:ZWS) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $28.70.
AI Creates New Cancer Drug - In Just 30 Days! (ad)
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Agilent Technologies (NYSE:A) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $140.00 price target on the stock. This represents a 8.3% upside from the current price of $129.27.
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $38.00 price target on the stock. This represents a 32.1% upside from the current price of $28.77.
Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $90.00 price target on the stock. This represents a 267.8% upside from the current price of $24.47.
Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating on the stock.The current price is $24.47.
Arrowroot Acquisition (NASDAQ:ARRW) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $18.00 price target on the stock. This represents a 71.4% upside from the current price of $10.50.
Avantor (NYSE:AVTR) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $21.26.
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $125.00 price target on the stock. This represents a 75.5% upside from the current price of $71.21.
Bruker (NASDAQ:BRKR) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $80.00 price target on the stock. This represents a 14.3% upside from the current price of $70.02.
Kanzhun (NASDAQ:BZ) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $20.00 price target on the stock. This represents a 33.0% upside from the current price of $15.04.
CAVA Group (NYSE:CAVA) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $46.00 price target on the stock. This represents a 21.2% upside from the current price of $37.94.
Cricut (NASDAQ:CRCT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $7.00 price target on the stock. This represents a 1.0% upside from the current price of $6.93.
Camping World (NYSE:CWH) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $30.00 price target on the stock. This represents a 26.3% upside from the current price of $23.76.
Danaher (NYSE:DHR) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $221.18.
Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $32.00 price target on the stock. This represents a 60.3% upside from the current price of $19.96.
DoubleVerify (NYSE:DV) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock. This represents a 14.4% upside from the current price of $34.96.
Exact Sciences (NASDAQ:EXAS) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $95.00 price target on the stock. This represents a 47.4% upside from the current price of $64.47.
Guardant Health (NASDAQ:GH) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $26.71.
HilleVax (NASDAQ:HLVX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock. This represents a 96.8% upside from the current price of $14.23.
Illumina (NASDAQ:ILMN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $175.00 price target on the stock. This represents a 44.3% upside from the current price of $121.24.
Microsoft (NASDAQ:MSFT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating on the stock.The current price is $374.05.
Myriad Genetics (NASDAQ:MYGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 45.0% upside from the current price of $19.31.
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $127.00 price target on the stock. This represents a 3.4% upside from the current price of $122.77.
Natera (NASDAQ:NTRA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $70.00 price target on the stock. This represents a 19.4% upside from the current price of $58.62.
Opera (NASDAQ:OPRA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $16.50 price target on the stock. This represents a 38.3% upside from the current price of $11.93.
Pacific Biosciences of California (NASDAQ:PACB) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $7.95.
Impinj (NASDAQ:PI) is now covered by analysts at Susquehanna. They set a "positive" rating and a $100.00 price target on the stock. This represents a 24.8% upside from the current price of $80.11.
Qiagen (NYSE:QGEN) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $41.93.
Roblox (NYSE:RBLX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $49.00 price target on the stock. This represents a 15.1% upside from the current price of $42.57.
Revvity (NYSE:RVTY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $93.43.
Acelyrin (NASDAQ:SLRN) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $11.00 price target on the stock. This represents a 80.9% upside from the current price of $6.08.
Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $113.00 price target on the stock. This represents a 26.3% upside from the current price of $89.47.
Standex International (NYSE:SXI) is now covered by analysts at DA Davidson. They set a "buy" rating and a $165.00 price target on the stock. This represents a 14.6% upside from the current price of $143.98.
Thermo Fisher Scientific (NYSE:TMO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $575.00 price target on the stock. This represents a 14.8% upside from the current price of $500.90.
10x Genomics (NASDAQ:TXG) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $55.00 price target on the stock. This represents a 14.7% upside from the current price of $47.97.
Veralto (NYSE:VLTO) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $77.29.
VIZIO (NYSE:VZIO) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock. This represents a 51.7% upside from the current price of $7.25.
Waters (NYSE:WAT) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $299.67.
Xylem (NYSE:XYL) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $127.00 price target on the stock. This represents a 19.0% upside from the current price of $106.74.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
Apple Inc. (AAPL) 
Amazon.com, Inc. (AMZN) 
Alphabet Inc. (GOOGL) 
Meta Platforms, Inc. (META) 
Microsoft Co. (MSFT) 
